09/11/2020 Amylyx Pharmaceuticals announces last participant completed final study visit of its PEGASUS Phase II trial for AD Science watch
07/11/2020 EIP Pharma reports results from Phase II study of neflamapimod in mild to moderate dementia with Lewy Bodies Science watch
05/11/2020 Findings from the LipiDiDiet clinical trial in prodromal Alzheimer’s disease indicate benefits in cognitive performance Science watch
04/11/2020 Cortexyme’s Phase II/II GAIN trial of COR388 in Alzheimer’s disease passes futility analysis Science watch
02/11/2020 Systematic analysis shows that Alzheimer’s disease and dementias are a leading cause of death from neurological disorders in the US Science watch
01/11/2020 Danish clinical research study shows that a healthy cardiovascular lifestyle can attenuate the genetic susceptibility to dementia Science watch
30/10/2020 Marketing authorisation application for Aducanumab accepted by European Medicines Agency Science watch
27/10/2020 Alzheon announces the recruitment of the first participant with early AD in Phase II trial of ALZ-801 Science watch
21/10/2020 MICOIL study in Greece finds that a diet rich in early harvest extra virgin olive oil may help protect against cognitive impairment Science watch
21/10/2020 Biogen has submitted the Marketing Authorization Application to EMA for aducanumab Science watch
